- Home
- Equipment
- north america
- hemorrhage stroke
Show results for
Refine by
Hemorrhage Stroke Equipment Supplied In North America
5 equipment items found
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
A revolutionary surgical solution for treating cerebral aneurysms. The Tubridge® Vascular Reconstruction Device is an aneurysm treatment solution designed with a revolutionary surgical concept. The treatment of aneurysms can be achieved by isolating the blood flow from the parent artery and changing / reconstructing the hemodynamics. The excellent release mechanism and wall apposition ...
Manufactured by:MicroPort Scientific Corporation based inShanghai, CHINA
Immediate Occlusion, Effective Exclusion. Willis® Intracranial Stent Graft system is a stent graft solution for the treatment of intracranial aneurysms. The immediate blood flow reconstruction can effectively isolate the blood flow between the aneurysm and the parent artery, while still keeping the blood flow to the parent artery unobstructed. This way, the hemodynamics of the lesion area is ...
Manufactured by:CervoMed based inBoston, MASSACHUSETTS (USA)
Our lead product candidate, Trans sodium crocetinate (TSC), is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine’s most intractable and difficult-to-treat conditions. ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
SP600125 is an orally active, reversible, and ATP-competitive JNK inhibitor with IC50s of 40, 40 and 90 nM for JNK1, JNK2 and JNK3, respectively. SP600125 is a potent ferroptosis inhibitor. SP600125 induces the transformation of bladder cancer cells from autophagy to ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Z-VAD(OMe)-FMK (Z-Val-Ala-Asp(OMe)-FMK) is a cell-permeable and irreversible pan-caspase inhibitor[1]. Z-VAD(OMe)-FMK is an ubiquitin carboxy-terminal hydrolase L1 (UCHL1) inhibitor. Z-VAD(OMe)-FMK irreversibly modifies UCHL1 by targeting the active site of ...